Intellia Therapeutics is trading at $12.95, up 5.46%, with biotech-sector strength the clearest available explanation.
- Biotech (XBI) is up 2.18% during the regular session, while broader indices are mixed.
- No clear company-specific headline explaining the October 28 move surfaced in the search.
- Intellia Therapeutics also rose 9.06% in the previous session; todayβs gain may extend recent momentum alongside the sector rally.